InvestorsHub Logo
Followers 119
Posts 4512
Boards Moderated 2
Alias Born 04/14/2014

Re: XenaLives post# 45275

Friday, 12/18/2015 10:59:06 AM

Friday, December 18, 2015 10:59:06 AM

Post# of 461224
Well I was going to point to the .pdf poster that showed, IIRC, two grey boxes for 2-73 near baseline and other boxes for donepezil low/mid-range and boxes for PLUS mid/high-range...but I can't find it! Old links to the website are dead and re-reading all the stuff about 2-73's properties while looking made me want to rest on that.

A2-73 certainly sports enough data on it's effects alone to call it remarkable. Maybe I am making more out of the PLUS patent than need be. It seems important when considering combo therapies in other indications, as suggested as possibilities.
§AVXL

Disclaimer

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News